Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.95 - $9.16 $1.93 Million - $3.56 Million
-389,035 Reduced 35.74%
699,531 $5.25 Million
Q4 2021

Feb 14, 2022

SELL
$7.02 - $13.33 $7.68 Million - $14.6 Million
-1,094,118 Reduced 50.13%
1,088,566 $7.64 Million
Q2 2021

Aug 16, 2021

BUY
$15.16 - $18.97 $1.74 Million - $2.18 Million
115,000 Added 5.56%
2,182,684 $34.9 Million
Q1 2021

May 17, 2021

SELL
$13.12 - $20.9 $2.1 Million - $3.34 Million
-159,927 Reduced 7.18%
2,067,684 $37 Million
Q3 2020

Nov 16, 2020

SELL
$10.46 - $14.46 $487,530 - $673,966
-46,609 Reduced 2.05%
2,227,611 $26.2 Million
Q2 2020

Aug 14, 2020

SELL
$12.0 - $16.13 $3.05 Million - $4.1 Million
-254,056 Reduced 10.05%
2,274,220 $33.6 Million
Q1 2020

May 15, 2020

BUY
$11.84 - $25.52 $1.36 Million - $2.93 Million
114,812 Added 4.76%
2,528,276 $34.1 Million
Q4 2019

Feb 14, 2020

BUY
$17.72 - $25.1 $10.3 Million - $14.6 Million
582,540 Added 31.82%
2,413,464 $58.3 Million
Q3 2019

Nov 14, 2019

BUY
$18.41 - $28.0 $33.7 Million - $51.3 Million
1,830,924 New
1,830,924 $35.2 Million
Q1 2019

May 15, 2019

SELL
$36.32 - $49.25 $68.8 Million - $93.3 Million
-1,893,935 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$33.0 - $60.04 $12 Million - $21.9 Million
-364,508 Reduced 16.14%
1,893,935 $68.4 Million
Q3 2018

Nov 13, 2018

SELL
$56.15 - $73.9 $25.9 Million - $34.1 Million
-461,775 Reduced 16.98%
2,258,443 $139 Million
Q2 2018

Aug 14, 2018

SELL
$47.85 - $70.45 $5.4 Million - $7.95 Million
-112,785 Reduced 3.98%
2,720,218 $184 Million
Q1 2018

May 15, 2018

BUY
$51.15 - $61.0 $11.5 Million - $13.8 Million
225,792 Added 8.66%
2,833,003 $154 Million
Q4 2017

Feb 14, 2018

BUY
$50.85 - $65.1 $9.85 Million - $12.6 Million
193,750 Added 8.03%
2,607,211 $156 Million
Q3 2017

Nov 14, 2017

BUY
$48.6 - $60.1 $117 Million - $145 Million
2,413,461
2,413,461 $117 Million

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.